Archives of Disease in Childhood 2007;92:1087; doi:10.1136/adc.2007.129692
Copyright © 2007 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health
Radiological findings in cyclical administration of intravenous pamidronate in children with osteoporosis
C Onwuneme,
K Abdalla,
N Cassidy,
O Hensey,
S Ryan
Childrens University Hospital, Temple Street, Dublin, Ireland
Correspondence to:
C Onwuneme, Childrens University Hospital, Temple Street, Dublin 1, Ireland; drchike2001@yahoo.com
| The first 150 words of the full text of this article appear below. |
A 5-year-old boy with moderately severe osteogenesis imperfecta and spontaneous fractures was treated with serial courses of intravenous pamidronate. Pamidronate is a second-generation bisphosphonate drug that binds strongly to bone mineral and interferes with bone remodelling by slowing osteoclastic bone resorption. It is used in a cyclic dosage of 1 mg/kg/day intravenously on 3 successive days at 4-monthly intervals. A radiograph of the knee after treatment showed a pattern of parallel dense metaphyseal lines (fig 1A).
View larger version (108K):
|
Figure 1 (A) A 5-year-old boy with osteogenesis imperfecta after cyclic treatment with biphosphonates. AP radiograph of the knee shows dense parallel bands in distal femoral and proximal tibial and fibular metaphyses. (B) A 16-year-old boy with camptodactyly coxavara arthropathy pericarditis syndrome (C-CAP syndrome) and osteoporosis who had cyclic treatment with biphosphonates. AP radiograph of the knee shows dense parallel bands in distal femoral and proximal tibial and fibular metaphyses. Lines are closer to . . . [Full text of this article] |
|
Terms and conditions relating to subscriptions purchased online ¦ Website terms and conditions ¦ Privacy policy
Copyright © 2007 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health